CH614698A5 - - Google Patents

Info

Publication number
CH614698A5
CH614698A5 CH57176A CH57176A CH614698A5 CH 614698 A5 CH614698 A5 CH 614698A5 CH 57176 A CH57176 A CH 57176A CH 57176 A CH57176 A CH 57176A CH 614698 A5 CH614698 A5 CH 614698A5
Authority
CH
Switzerland
Application number
CH57176A
Inventor
George A Hashim
Original Assignee
St Lukes Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Lukes Hospital filed Critical St Lukes Hospital
Publication of CH614698A5 publication Critical patent/CH614698A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH57176A 1975-01-20 1976-01-19 CH614698A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54217575A 1975-01-20 1975-01-20

Publications (1)

Publication Number Publication Date
CH614698A5 true CH614698A5 (xx) 1979-12-14

Family

ID=24162652

Family Applications (1)

Application Number Title Priority Date Filing Date
CH57176A CH614698A5 (xx) 1975-01-20 1976-01-19

Country Status (8)

Country Link
US (1) US4113858A (xx)
BE (1) BE837741A (xx)
CA (1) CA1092600A (xx)
CH (1) CH614698A5 (xx)
FR (1) FR2297633A1 (xx)
GB (1) GB1528336A (xx)
IL (1) IL48862A (xx)
ZA (1) ZA76308B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230696A (en) * 1972-12-14 1980-10-28 St. Luke's Hospital Polypeptides useful for the purpose of treating multiple sclerosis
EP0000252B1 (en) * 1977-06-29 1982-02-03 Beecham Group Plc Peptides, pharmaceutical compositions containing the peptides and a process for the preparation of the peptides
DE2860579D1 (en) * 1977-09-07 1981-04-23 Sandoz Ag Polypeptides, their preparation and pharmaceutical compositions containing them
SE446866B (sv) * 1977-11-15 1986-10-13 Sloan Kettering Inst Cancer Sett att framstella en aktiv polypeptid med formaga att inducera differentiering av bade t-lymfocyter och komplementreceptor (cr?72+) b-lymfocyter
US4215111A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Peptides having ubiquitin-like activity
US4294818A (en) * 1979-07-30 1981-10-13 University Patents, Inc. Methods and materials for detection of multiple sclerosis
US4331145A (en) * 1981-01-28 1982-05-25 Arthur Winter Multiple sclerosis treatment
US4491541A (en) * 1982-11-10 1985-01-01 Farmitalia Carlo Erba Peptides
IT1218472B (it) * 1985-08-30 1990-04-19 Alfio Bertolini Composizioni farmaceutiche comprendenti acht (1-24) per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
US6252040B1 (en) * 1991-10-22 2001-06-26 The Governors Of The University Of Alberta Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
DE4211878C2 (de) * 1992-04-09 1995-04-20 Ralf Dr Med Kluge Mittel zur Behandlung der Multiplen Sklerose
NZ259636A (en) * 1992-12-18 1997-10-24 Molecular Rx Inc Hybridomas which produce monoclonal antibodies specific for multiple sclerosis and their use in diagnostic assays
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
EP1511477A4 (en) 2002-05-22 2008-04-09 Errant Gene Therapeutics Llc HISTONE DEACETYLASE INHIBITORS BASED ON ALPHA-KETO-EPOXYDE COMPOUNDS
WO2004046104A2 (en) * 2002-11-20 2004-06-03 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
US8034777B2 (en) * 2004-09-23 2011-10-11 Receptopharm, Inc. Modified anticholinergic neurotoxins as modulators of the autoimmune reaction
EP1817020A4 (en) * 2004-11-08 2012-11-21 Errant Gene Therapeutics Inc INHIBITORS OF HISTONATE ACETYLASE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1310534A (fr) * 1961-07-26 1962-11-30 Ciba Geigy Procédé de préparation de nouveaux polypeptides, notamment du nonadécapeptide de formule l-séryl-l-tyrosyl-l-séryl-l-(chi)-l-glutaminyl-l-histidyl-l-phénylalanyl-l-arginyl-l-tryptophyl-glycyl-l-lysyl-l-prolyl-l-valvyl-glycyl-l-lysyl-l-lysyl-l-arginyl-l-arginyl-l-proline
CH427842A (de) * 1960-07-29 1967-01-15 Ciba Geigy Verfahren zur Herstellung neuer Polypeptide
GB1053177A (xx) * 1961-05-04
NL278010A (xx) * 1961-05-04 1900-01-01
US3864481A (en) * 1972-12-14 1975-02-04 St Lukes Hospital Anti disease producing synthetic material for the prevention suppression and diagnosis of multiple sclerosis and method of treatment therefor
US3941162A (en) * 1974-03-28 1976-03-02 Uniroyal Inc. Reinforcing fabric for belts

Also Published As

Publication number Publication date
CA1092600A (en) 1980-12-30
US4113858A (en) 1978-09-12
GB1528336A (en) 1978-10-11
FR2297633A1 (fr) 1976-08-13
ZA76308B (en) 1977-01-26
IL48862A (en) 1980-12-31
FR2297633B1 (xx) 1979-02-23
BE837741A (fr) 1976-05-14
IL48862A0 (en) 1976-03-31

Similar Documents

Publication Publication Date Title
FR2297633B1 (xx)
CH336076A4 (xx)
CH574010A5 (xx)
BG22239A1 (xx)
BG22250A1 (xx)
BG22315A1 (xx)
BG23308A1 (xx)
BG23425A1 (xx)
CH1092575A4 (xx)
CH591312A5 (xx)
CH582390A5 (xx)
CH584094A5 (xx)
CH586474A5 (xx)
CH587515B5 (xx)
CH587608A5 (xx)
CH589160A5 (xx)
CH591038A5 (xx)
CH591249A5 (xx)
CH591715A5 (xx)
CH592518A5 (xx)
CH592786A5 (xx)
CH593053A5 (xx)
CH594270A5 (xx)
CH594863A5 (xx)
AU479572A (xx)

Legal Events

Date Code Title Description
PL Patent ceased